Mediclin AG
XETRA:MED
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.3
2.96
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MED stock under the Base Case scenario is 20.28 EUR. Compared to the current market price of 2.56 EUR, Mediclin AG is Undervalued by 87%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Mediclin AG
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Mediclin AG
Balance Sheet Decomposition
Mediclin AG
Current Assets | 319.3m |
Cash & Short-Term Investments | 193.2m |
Receivables | 113.3m |
Other Current Assets | 12.8m |
Non-Current Assets | 584.8m |
Long-Term Investments | 60.9k |
PP&E | 518.2m |
Intangibles | 22.1m |
Other Non-Current Assets | 44.4m |
Current Liabilities | 183.8m |
Accounts Payable | 9.5m |
Other Current Liabilities | 174.3m |
Non-Current Liabilities | 508m |
Long-Term Debt | 424.3m |
Other Non-Current Liabilities | 83.7m |
Earnings Waterfall
Mediclin AG
Revenue
|
771.1m
EUR
|
Cost of Revenue
|
-129.6m
EUR
|
Gross Profit
|
641.5m
EUR
|
Operating Expenses
|
-623.7m
EUR
|
Operating Income
|
17.8m
EUR
|
Other Expenses
|
-29m
EUR
|
Net Income
|
-11.2m
EUR
|
Free Cash Flow Analysis
Mediclin AG
EUR | |
Free Cash Flow | EUR |
MED Profitability Score
Profitability Due Diligence
Mediclin AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Mediclin AG's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
MED Solvency Score
Solvency Due Diligence
Mediclin AG's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
Mediclin AG's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MED Price Targets Summary
Mediclin AG
According to Wall Street analysts, the average 1-year price target for MED is 4.36 EUR with a low forecast of 3.84 EUR and a high forecast of 4.99 EUR.
Dividends
Current shareholder yield for MED is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg and currently employs 7,115 full-time employees. The company went IPO on 2000-12-04. The firm operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).
Contact
IPO
Employees
Officers
The intrinsic value of one MED stock under the Base Case scenario is 20.28 EUR.
Compared to the current market price of 2.56 EUR, Mediclin AG is Undervalued by 87%.